about
Oocyte maturation and quality: role of cyclic nucleotidesIn vitro maturation (IVM) of oocytes recovered from ovariectomy specimens in the laboratory: a promising "ex vivo" method of oocyte cryopreservation resulting in the first report of an ongoing pregnancy in EuropeHuman cumulus-enclosed germinal vesicle oocytes from early antral follicles reveal heterogeneous cellular and molecular features associated with in vitro maturation capacityEffects of long-term in vitro exposure to phosphodiesterase type-3 inhibitors on follicle and oocyte development.Meiotic arrest in vitro by phosphodiesterase 3-inhibitor enhances maturation capacity of human oocytes and allows subsequent embryonic development.Oocyte maturity and preimplantation development in relation to follicle diameter in gonadotropin-releasing hormone agonist or antagonist treatments.Cortisol is an associated-risk factor of brain dysfunction in patients with severe sepsis and septic shockCulture of oocytes and risk of imprinting defects.The cumulus cell gene expression profile of oocytes with different nuclear maturity and potential for blastocyst formationFertility preservation in women with cancer.Exogenous hCG activity, but not endogenous LH activity, is positively associated with live birth rates in anovulatory infertility.Vitrification of human ovarian tissue: a practical and relevant alternative to slow freezingThe value of anti-Mullerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments.Immature oocyte in-vitro maturation: clinical aspects.Live-birth rates after HP-hMG stimulation in the long GnRH agonist protocol: association with mid-follicular hCG and progesterone concentrations, but not with LH concentrations.The current knowledge on radiosensitivity of ovarian follicle development stages.The effect of ovarian puncture on the endocrine profile of PCOS patients who undergo IVMLuteinizing hormone and human chorionic gonadotropin: distinguishing unique physiologic rolesThe promise of in vitro maturation in assisted reproduction and fertility preservation.Molecular control of oogenesis.Can anti-Müllerian hormone concentrations be used to determine gonadotrophin dose and treatment protocol for ovarian stimulation?Luteinizing hormone and human chorionic gonadotropin: origins of difference.Follicle-Stimulating Hormone: A Review of Form and Function in the Treatment of Infertility.Neurokinin B Exerts Direct Effects on the Ovary to Stimulate Estradiol Production.Sheep Isolated Secondary Follicles Are Able to Produce Metaphase II Oocytes After Vitrification and Long-Term In Vitro Growth.The loss of imprinted DNA methylation in mouse blastocysts is inflicted to a similar extent by in vitro follicle culture and ovulation induction.Zona pellucida gene mRNA expression in human oocytes is related to oocyte maturity, zona inner layer retardance and fertilization competence.The definition of IVM is clear-variations need defining.Vitamin D deficiency and pregnancy rates in women undergoing single embryo, blastocyst stage, transfer (SET) for IVF/ICSI.Ovine secondary follicles vitrified out the ovarian tissue grow and develop in vitro better than those vitrified into the ovarian fragments.High prolactin levels are associated with more delirium in septic patients.Connexin 37 and 43 gene and protein expression and developmental competence of isolated ovine secondary follicles cultured in vitro after vitrification of ovarian tissue.A "freeze-all" embryo strategy after in vitro maturation: a novel approach in women with polycystic ovary syndrome?Clinical outcome of non-hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome.Chromosome constitution of human embryos generated after in vitro maturation including 3-isobutyl-1-methylxanthine in the oocyte collection medium.A randomized controlled dose-response pilot study of addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization.Effects of low methyl donor levels in culture medium during mouse follicle culture on oocyte imprinting establishment.Cumulus cell gene expression is associated with oocyte developmental quality and influenced by patient and treatment characteristics.Cumulus cell gene expression predicts better cleavage-stage embryo or blastocyst development and pregnancy for ICSI patients.Reply: HCG supplementation of controlled ovarian stimulation cycles.
P50
Q28074819-670D1784-83D4-4672-B07F-1E73DD8A868CQ28265984-3E22F485-030B-4CBF-97D0-FE1917CBD25EQ29027343-7A189E02-2593-4AA3-A132-38B189E03B4CQ33220472-1E3A928F-A4B9-4887-8D31-ED28B3BDFF66Q33224659-FA194506-9929-4A33-83E9-7E3341677EA1Q33234714-9ECE2FD2-2EA0-48E8-805D-737ABD47D0BBQ33616353-C5ACC8BA-FDDF-4604-A483-598BC1D00860Q34305206-F52B757F-A8E8-41CB-9FB2-EADEEDE9DE02Q34608678-6B0925BA-D0DD-4021-81C4-14AD60965E46Q34729392-7931CF03-F9E7-4176-8A97-5B167DCCC81AQ35650609-93A76607-380F-4E1E-9602-23993017F22CQ35782321-1450724F-DD24-4D2B-8A5C-20619FC24143Q35976287-15F1FE4F-385F-4384-8CDC-EA9286DF9DCFQ36159111-31DF7D22-7F52-45E0-84CA-7B49C767F7E4Q36456037-729E0ABF-8BD7-4E74-8EAF-681A07C6C4E8Q37371374-FC7D2235-BE3F-4F46-A918-1DDFFE550B74Q37607260-55EA4EBF-1AAC-44A3-9B59-D306D44CB1E8Q37641680-97DEF775-C7F0-4D31-B4B5-0A15F94896E6Q37826138-6AF2B1DB-58A3-4EB5-AC38-64C59C40A0A5Q38013504-CEED8DE0-1A6F-4A57-A942-00EC019ABF38Q38090852-EE15ABE1-5ADE-4036-9E9B-45C3EB867F85Q38173508-14AF86A1-8BC3-432A-88D4-3E2E613C7F4CQ38601686-2011B565-C0FA-4838-BE8A-981E01E39E18Q38748848-1EA531B2-0D0D-402B-A8E6-7AC729CD08F8Q38844670-D3B1B10C-4003-4B2B-9215-46EE8D565A4BQ38904202-48CA853D-551F-4C10-B390-A4008EF592F4Q38958820-87BFE344-BEA9-4A10-B843-1E46841E1EDBQ38963451-7E04E945-B372-4971-9D13-504680112044Q39172429-C95E5563-0109-47E4-9B1C-12874C7835FFQ40017707-33C46A09-9959-48DA-BAD4-0476AF6F4B6DQ40801795-2B6D24DC-9BF5-443B-819E-AF4B51B0AC60Q41599408-45B9D51A-1549-40E1-A85E-B19B82C98E33Q41604137-D94280A5-18CF-4436-91C3-7979660C7F6CQ41607197-AB3006B6-4501-4DEE-BDD6-CD50151F676EQ41726893-6D9CBB64-E9D5-4AA4-97E0-B66FD02F3E8EQ42658780-ABD5EE2D-0DD5-4881-8C52-E497203E2234Q43099122-4D63F3D4-20B4-4284-BFA4-3D930A541FE9Q43130188-7D77F652-2D3D-4189-B690-6F9DE3784509Q43672237-7B1AF096-1E16-441A-8B0A-F6A8AC2DA801Q43787192-F504D388-437F-4019-BA49-B24883E1E86D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Johan Smitz
@ast
Johan Smitz
@en
Johan Smitz
@es
Johan Smitz
@nl
type
label
Johan Smitz
@ast
Johan Smitz
@en
Johan Smitz
@es
Johan Smitz
@nl
prefLabel
Johan Smitz
@ast
Johan Smitz
@en
Johan Smitz
@es
Johan Smitz
@nl
P106
P1153
55112867600
P31
P496
0000-0002-5857-6542